Seeking men and women with advanced (Stage III or IV) melanoma for a study of whether adding an investigational drug to an FDA approved drug combination is safe and effective.
We are studying whether adding an investigational drug to the usual drug combination is safe and improves the therapy's antitumor effects. Participants will be randomly assigned to receive the usual drug combination alone or the usual drub combination and the investigational drug.
What we're hoping for
We hope that adding the investigational drug to usual FDA approved drug combination for advanced melanoma will be safe and improve the therapy's antitumor effects.
ClinicalTrials.gov Identifier: NCT02339571